MARKET

ANIX

ANIX

Anixa Biosciences Inc
NASDAQ
4.740
-0.110
-2.27%
After Hours: 4.769 +0.029 +0.61% 17:44 12/04 EST
OPEN
4.820
PREV CLOSE
4.850
HIGH
4.850
LOW
4.640
VOLUME
202.48K
TURNOVER
--
52 WEEK HIGH
4.980
52 WEEK LOW
2.070
MARKET CAP
156.03M
P/E (TTM)
-13.7551
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 1d ago
Weekly Report: what happened at ANIX last week (1124-1128)?
Weekly Report · 3d ago
Weekly Report: what happened at ANIX last week (1117-1121)?
Weekly Report · 11/24 10:28
Anixa Biosciences’ CAR-T therapy granted WHO approval of non-proprietary name
TipRanks · 11/17 13:20
Anixa Biosciences Secures WHO Approval for CAR-T Therapy Name
Reuters · 11/17 13:15
ANIXA BIOSCIENCES ANNOUNCES WORLD HEALTH ORGANIZATION (WHO) APPROVAL OF INTERNATIONAL NON-PROPRIETARY NAME FOR ITS CAR-T THERAPY, MARKING A KEY MILESTONE TOWARD GLOBAL RECOGNITION AND FUTURE COMMERCIALIZATION
Reuters · 11/17 13:15
Weekly Report: what happened at ANIX last week (1110-1114)?
Weekly Report · 11/17 10:28
Anixa Biosciences: Hard To Justify The Market's Optimism With An Upcoming Phase 1 Readout
Seeking Alpha · 11/12 16:48
More
About ANIX
Anixa Biosciences, Inc. is a clinical-stage biotechnology company focused on the treatment and prevention of cancer. The Company's therapeutic portfolio consists of an ovarian cancer immunotherapy program being developed in collaboration with Moffitt Cancer Center, which uses a novel type of CAR-T, known as chimeric endocrine receptor-T cell (CER-T) technology. The Company's vaccine portfolio includes vaccines being developed in collaboration with Cleveland Clinic to treat and prevent breast cancer and ovarian cancer, as well as additional cancer vaccines to address many intractable cancers, including high incidence malignancies in lung, colon, and prostate. The Company is engaged in the development of vaccines for the treatment or prevention of triple negative breast cancer and other breast cancers which express the a-lactalbumin protein. Its vaccine technologies are focused on immunizing against retired proteins that have been found to be expressed in certain forms of cancer.

Webull offers Anixa Biosciences Inc stock information, including NASDAQ: ANIX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANIX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANIX stock methods without spending real money on the virtual paper trading platform.